PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules.

Geng, Qiaohong; Jiao, Peifu; Jin, Peng; Su, Gaoxing; Dong, Jinlong; Yan, Bing

Geng, Qiaohong; Jiao, Peifu; Jin, Peng; Su, Gaoxing; Dong, Jinlong; Yan, Bing.

Afiliación

Geng Q; Department of Chemistry, Qilu Normal University, Jinan, Shandong 250013, China.
Jiao P; Department of Chemistry, Qilu Normal University, Jinan, Shandong 250013, China.
Jin P; Department of Chemistry, Qilu Normal University, Jinan, Shandong 250013, China.
Su G; School of Pharmacy, Nantong University, Nantong, Jiangsu 226001, China.
Dong J; Jinan Taorui Pharma & Tech Co., Ltd., Jinan, Shandong 250101, China.
Yan B; School of Environmental Science and Engineering, Shandong University, Jinan, Shandong 250100, China.

Curr Pharm Des ; 23(39): 6033-6041, 2018 02 12.

Article en En | MEDLINE | ID: mdl-28982322

Asunto(s)

Anticuerpos/inmunología; Antígeno B7-H1/antagonistas & inhibidores; Neoplasias/terapia; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Bibliotecas de Moléculas Pequeñas/farmacología; Animales; Antígeno B7-H1/metabolismo; Humanos; Inmunoterapia; Ratones; Neoplasias/inmunología; Neoplasias/metabolismo; Receptor de Muerte Celular Programada 1/metabolismo; Bibliotecas de Moléculas Pequeñas/química

Palabras clave

Cancer immunotherapy; peptides; small molecules; structure-activity relationships; therapeutic antibody; tumor cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bibliotecas de Moléculas Pequeñas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos / Neoplasias Idioma: En Revista: Curr Pharm Des Asunto de la revista: FARMACIA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google